In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: PRA Group's current price exceeds the weighted fair value of $17.18, suggesting potential overvaluation supported by analyst targets near $25 but contradicted by negative DCF results. Financial health presents mixed signals: strong leverage and growth scores contrast with zero profitability and efficiency. Monte Carlo analysis reveals significant downside risk, indicating high investment volatility.